NextCure, Inc. (NXTC)
Nasdaq: NXTC · Pharmaceutical Preparations · Beltsville, MD · filing with the SEC since 2016
Who owns NextCure, Inc.
As filed with the SECHolders of 5% or more
7
ADAR1 Capital Management, LLC holds 15.8% of Common Stock, $0.001 par value per share, as its SCHEDULE 13G filed Aug 14, 2026 says.
Directors and officers
12
report now, of 25 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
ADAR1 Capital Management, LLC
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, $0.001 par value per share
Ikarian Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.001 par value per share · 9.99% in Feb 17, 2026
JP Sailing Capital Ltd
SCHEDULE 13G · filed Oct 20, 2026 · Common Stock, $0.001 par value per share
Simcere Zaiming, Inc.
SCHEDULE 13G/A · filed May 6, 2026 · Common Stock, par value $0.001 per share · 12.7% in Aug 19, 2025
Adage Capital Management, L.P.
SCHEDULE 13G · filed Aug 12, 2026 · Common Stock, par value $0.001 per share
Sofinnova Venture Partners IX, L.P. ("SVP IX")
SCHEDULE 13D/A · filed Mar 5, 2026 · Common Stock, $0.001 par value
Affinity Asset Advisors, LLC
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, $0.001 par value per share · 9.99% in Jan 29, 2026
SilverArc Capital Management, LLC
SCHEDULE 13G/A · filed May 13, 2026 · Class A Common Stock · reported falling below 5%, from 5.02% in Feb 12, 2026
Citigroup Inc.
SCHEDULE 13G · filed May 12, 2025 · Common Stock · reported falling below 5%
Pfizer Inc.
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock par value $0.001 per share · reported falling below 5%
Squadron Master Fund LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.001 par value per share · reported falling below 5%, from 9.9% in Feb 17, 2026
Logos Global Management LP
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock · reported falling below 5%
What NXTC reports owning in othersstakes of 5% or more, and other ties
NextCure, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 9, 2025 to Nov 9, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2019 runs to Nov 9, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 42 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. | 10% owner | 1 | $200,000 | 0 | 0 | $0 |
| Adar1 Capital Management, LLC | 10% owner | 0 | $0 | 0 | 18 | $1.8M |